authID ($AUID) Signs Deal with Microsoft Partner
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
Company Research
scPharmaceuticals ($SCPH) – Tender Date and Details
MannKind has announced the tender date for scPharma is October 6th, 2025. If you want to own the contingent value right (CVR), you should keep your shares and tender them in the offer. If you don’t want to own the CVR, then you should sell your shares prior to October 6th. The documents filed … Read more
Mailbag – Subscriber Questions
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
Another Great Month in Macau
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
New Feature – Let’s Talk!
Hi All, Good news. As promised, we’ve implemented a new meeting feature. I’ve opened up two 30 minute slots every Monday starting after the coming holiday weekend. These are private Zoom meetings to discuss whatever is on your mind. Flying V’s Kashif has worked some cool magic here so if you’re a DKI Premium Subscriber … Read more
scPharmaceuticals ($SCPH) – Educational Lessons from a Deal
At DKI, we’ve been making an effort to be more transparent in how we make investment decisions and to provide more educational content. There are several interesting lessons which can be extracted from the recent scPharma takeover announcement. Before we dive in, I want to be clear that while a likely acquisition was a key … Read more
scPharmaceuticals ($SCPH) – Being Acquired by MannKind for a Large Premium
MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone. This is the second DKI healthcare device portfolio company acquired in the past two … Read more
scPharmaceuticals ($SCPH) Being Acquired – Large Premium
MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone. I’m listening to the conference call right now and will update you later today when … Read more
The Prove Webinar Series
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
Seeking Alpha on $AUID
Seeking Alpha had a recap of last night’s authID ($AUID) conference call. It’s worth a quick read and contains a link to the transcript for those of you who want more detail. It was written by AI, but in my opinion, does a nice job capturing the important information. https://seekingalpha.com/news/4485845-authid-targets-18m-in-2025-bookings-as-idx-platform-launch-expands-total-addressable-market Information contained in … Read more
